Navigation Links
Sunrise to Host Conference Call and Webcast to Discuss First-Quarter 2009 Financial Results
Date:5/1/2009

MCLEAN, Va., May 1 /PRNewswire-FirstCall/ -- Sunrise Senior Living, Inc. (NYSE: SRZ) today announced that it will host a conference call and Webcast on Friday, May 8, 2009, at 9 a.m. ET to discuss its financial results for the first-quarter 2009. Mark Ordan, chief executive officer, Richard Nadeau, chief financial officer, and Julie Pangelinan, chief accounting officer, will host the call.

The call-in number for the conference call is 877-719-9796 or 719-325-4827 (from outside the U.S.). Callers should reference the "Sunrise Senior Living Q1 Earnings Call" or the participant passcode: 1059514. Those interested may also go to the Investor Relations section of the Company's Web site (http://www.sunriseseniorliving.com) to listen to the earnings call. A telephone replay of the call will be available until May 22 at 12 p.m. ET, by dialing 888-203-1112 or 719-457-0820 (passcode: 1059514); a replay will also be available on Sunrise's Web site during that period.

About Sunrise Senior Living

Sunrise Senior Living, a McLean, Va.-based Company, employs approximately 40,000 people. As of December 31, 2008, Sunrise operated 435 communities in the United States, Canada, Germany and the United Kingdom, with a combined capacity for approximately 54,000 residents. Sunrise offers a full range of personalized senior living services, including independent living, assisted living, care for individuals with Alzheimer's and other forms of memory loss, as well as nursing, rehabilitative and hospice care. Sunrise's senior living services are delivered by staff trained to encourage the independence, preserve the dignity, enable freedom of choice and protect the privacy of residents. To l
'/>"/>

SOURCE Sunrise Senior Living, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Sunrise Signs Twelfth Amendment to Bank Credit Facility through December 2, 2009
2. All Persons Who Purchased or Acquired the Common Stock of Sunrise Senior Living, Inc. (Sunrise) Between February 26, 2004 and July 28, 2006, Inclusive, and Were Damaged Thereby (The Class)
3. Sunrise Reports Financial Results for Fourth Quarter and Full-Year 2008
4. Sunrise to Host Conference Call and Webcast to Discuss Fourth-Quarter and Full-Year 2008 Financial Results
5. Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide
6. Sunrise Receives Proceeds from Venture Refinancing
7. Sunrise Reports Financial Results for Third Quarter 2008
8. Sunrise Provides Update on HCN Transaction
9. Sunrise to Host Conference Call and Webcast to Discuss the Companys Financial Results for the Third Quarter 2008
10. Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board
11. Sunrise Files 2007 Form 10-K
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 2Mach 7 Technologies Contracted by Singapore General Hospital to Provide State-of-the-Art Patient Image Management Technology 3Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 1New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 2New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 3New Pixantrone Phase III Data to be Presented at the 51st Annual Meeting of the American Society of Hematology 62405 4Outpatient disc treatment gives long term back pain relief 62403 1Outpatient disc treatment gives long term back pain relief 62403 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 1State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 2State Approves Plans For Kidney Transplants At Advocate Christ Medical Center 62400 3